BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34661962)

  • 1. Tanshinone IIA inhibits gastric cancer cell stemness through inducing ferroptosis.
    Ni H; Ruan G; Sun C; Yang X; Miao Z; Li J; Chen Y; Qin H; Liu Y; Zheng L; Xing Y; Xi T; Li X
    Environ Toxicol; 2022 Feb; 37(2):192-200. PubMed ID: 34661962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation.
    Guan Z; Chen J; Li X; Dong N
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity.
    Qin J; Shi H; Xu Y; Zhao F; Wang Q
    Biomed Pharmacother; 2018 Sep; 105():758-765. PubMed ID: 29909343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on optimisation of extraction process of tanshinone IIA and its mechanism of induction of gastric cancer SGC7901 cell apoptosis.
    Hou J; He J; Jin X; Hu T; Zhang Y
    Afr J Tradit Complement Altern Med; 2013; 10(6):456-8. PubMed ID: 24311868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone IIA attenuates the stemness of breast cancer cells via targeting the miR-125b/STARD13 axis.
    Li X; Jia Q; Zhou Y; Jiang X; Song L; Wu Y; Wang A; Chen W; Wang S; Lu Y
    Exp Hematol Oncol; 2022 Jan; 11(1):2. PubMed ID: 35057866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis.
    Ni H; Qin H; Sun C; Liu Y; Ruan G; Guo Q; Xi T; Xing Y; Zheng L
    Stem Cell Res Ther; 2021 Jun; 12(1):325. PubMed ID: 34090492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tanshinone IIA ameliorates cisplatin-induced toxicology and cisplatin resistance via regulating SLC7A11 expression.
    Qin H; Yuan Y; Yuan M; Yi S; Yang Y; Zhang Y
    Environ Toxicol; 2024 Mar; 39(3):1429-1441. PubMed ID: 37987512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIA.
    Xu Z; Chen L; Xiao Z; Zhu Y; Jiang H; Jin Y; Gu C; Wu Y; Wang L; Zhang W; Zuo J; Zhou D; Luan J; Shen J
    Phytomedicine; 2018 Dec; 51():58-67. PubMed ID: 30466628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA induces growth inhibition and apoptosis in gastric cancer in vitro and in vivo.
    Chen J; Shi DY; Liu SL; Zhong L
    Oncol Rep; 2012 Feb; 27(2):523-8. PubMed ID: 22038415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
    Su CC
    Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tanshinone I induces ferroptosis in gastric cancer cells via the KDM4D/p53 pathway.
    Xia M; Wu Y; Zhu H; Duan W
    Hum Exp Toxicol; 2023; 42():9603271231216963. PubMed ID: 37989263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
    Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
    Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization.
    Wang WQ; Liu L; Sun HC; Fu YL; Xu HX; Chai ZT; Zhang QB; Kong LQ; Zhu XD; Lu L; Ren ZG; Tang ZY
    J Hematol Oncol; 2012 Nov; 5():69. PubMed ID: 23137165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tanshinone IIA inhibits leukemia THP-1 cell growth by induction of apoptosis.
    Liu JJ; Zhang Y; Lin DJ; Xiao RZ
    Oncol Rep; 2009 Apr; 21(4):1075-81. PubMed ID: 19288011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanshinone IIA destabilizes SLC7A11 by regulating PIAS4-mediated SUMOylation of SLC7A11 through KDM1A, and promotes ferroptosis in breast cancer.
    Luo N; Zhang K; Li X; Hu Y; Guo L
    J Adv Res; 2024 Apr; ():. PubMed ID: 38615741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on HepG2 cells in relation to glutathione perturbation.
    Lee WY; Chiu LC; Yeung JH
    Food Chem Toxicol; 2008 Jan; 46(1):328-38. PubMed ID: 17892911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tanshinone sensitized the antitumor effects of irradiation on laryngeal cancer via JNK pathway.
    Xu H; Hao YL; Xu LN; Chen L; Xu FW
    Cancer Med; 2018 Oct; 7(10):5187-5193. PubMed ID: 30239172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer.
    Lu Q; Zhang P; Zhang X; Chen J
    Int J Mol Med; 2009 Dec; 24(6):773-80. PubMed ID: 19885617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshinone IIA reduces secretion of pro‑angiogenic factors and inhibits angiogenesis in human colorectal cancer.
    Zhou L; Sui H; Wang T; Jia R; Zhang Z; Fu J; Feng Y; Liu N; Ji Q; Wang Y; Zhang B; Li Q; Li Y
    Oncol Rep; 2020 Apr; 43(4):1159-1168. PubMed ID: 32323837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POLQ inhibition attenuates the stemness and ferroptosis resistance in gastric cancer cells via downregulation of dihydroorotate dehydrogenase.
    Peng Y; Zheng W; Chen Y; Lei X; Yang Z; Yang Y; Liang W; Sun K; Li G; Yu J
    Cell Death Dis; 2024 Apr; 15(4):248. PubMed ID: 38575587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.